Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

January 07, 2019 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its product portfolio to offer genes up to five kilobases (5kb) in length at industry-leading pricing. In addition, Twist is making its... Read more

QIAGEN unveils plans for next-generation digital PCR systems

Hilden, Germany, and Germantown, Maryland, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the development of a range of next-generation systems for digital polymerase chain reaction (digital PCR or dPCR), one of the fastest-growing molecular testing applications in the life sciences industry. QIAGEN expects to launch a fully integrated... Read more

QIAGEN launches QIAcube Connect – next-generation automation for sample processing in research labs

Hilden, Germany, and Germantown, Maryland, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAcube Connect, which marks the next generation of QIAGEN’s widely used QIAcube instrument and is designed to bring the benefits of automated sample processing solution to a new level. QIAcube Connect offers greatly enhanced... Read more

Paragon Genomics Partners with MGI Tech to Distribute its CleanPlex® NGS Target Enrichment Panels Worldwide

–Subsidiary of BGI Group Will Distribute CleanPlex® NGS Target Enrichment Panels Optimized for Its MGISEQ and BGISEQ Sequencing Platforms in All Territories Outside the U.S.– –Paragon Genomics Will Distribute MGI’s Automated Sample Preparation Systems in the U.S. and Canada with Optimized CleanPlex Chemistries Providing a Complete Automated Solution– HAYWARD, CA – January 6, 2019 –... Read more

Christine Tsingos Announces Plans to Retire as CFO of Bio-Rad Laboratories, Inc. Effective April 30, 2019

Date: 01/03/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Christine A. Tsingos has informed the company of her intention to retire as Executive Vice President and Chief Financial Officer effective April 30, 2019. Ms. Tsingos will remain in her current... Read more

Lexogen upgrades the TeloPrime Full-Length cDNA Amplification Kit empowering multiple downstream applications

Vienna, Austria, December 17, 2018 / PRNewswire/ – Today Lexogen launches a Version 2 (V2) upgrade for the TeloPrime Full-Length cDNA Amplification Kit; an all-in-one protocol for generating 5’ cap-specific full-length cDNA from as little as 1 ng of total RNA. The new TeloPrime V2 Kits provide higher yields and enhanced representation of longer cDNAs than the... Read more

Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services

December 18, 2018 ~ Services and Capacity Increase with New Site Opening ~ (San Diego, Calif., December 13, 2018) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has recently announced the expansion of its existing translational oncology research capacity by opening... Read more

10x Genomics Acquires Spatial Transcriptomics

Stakes Claim in Emerging Spatial Genomics Space PLEASANTON, CA.—December 10, 2018—10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight... Read more

Merck KGaA, Darmstadt, Germany Announces a CRISPR/Cas9 Strategic Alliance to Develop Rodent Models with genOway

10 DEC 2018 | DARMSTADT, GERMANY genOway to acquire exclusive rights to Merck’s foundational genome-editing patents to produce, sell rodent models New technologies and solutions to be developed using CRISPR/Cas9 to accelerate delivery of better drugs to patients Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in genome editing, announced that its life... Read more

Illumina Announces a New Genotyping Array and Scientific Contribution to Three Genome Centers to Support the All of Us Research Program

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the launch of its new high-density genotyping array, the Infinium™ Global Diversity Array. This new array was developed for and inspired by the All of Us Research Program. The All of Us Research Program is a historic effort to gather data from one million or more people living in... Read more